Literature DB >> 10320642

Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor.

P Welker1, J Grabbe, B Gibbs, T Zuberbier, B M Henz.   

Abstract

Stem cell factor (SCF), characterized as mast cell growth factor, is known to be produced by fibroblasts, keratinocytes and endothelial cells. Two different splice variants encode for either a soluble (SCF-1) or a membrane-bound (SCF-2) form. In order to explore whether mast cells themselves can produce SCF, we examined cultured cord blood (CBMC) and peripheral-blood-derived mast cells (PBMC), mast/basophil cell lines (HMC-1 and KU-812), and skin mast cells for SCF expression. On immunocytochemistry, cytoplasmatic SCF-reactivity was observed in HMC-1 cells, with additional cell membrane staining in KU-812, skin and cultured mast cells. Low amounts of SCF could be detected by ELISA in lysates of isolated and unstimulated mast cells and in supernatants of skin cells stimulated with anti-IgE or Ca-ionophore A23187. SCF mRNA was detected in all cells, although marked quantitative differences were observed among the various cell types. SCF-2 mRNA expression was low in HMC-1 cells while it was marked in skin mast cells, KU-812 cells, CBMC and PBMC. A time-dependent, increasing induction of both SCF forms was seen in CBMC and PBMC during culture. After stimulation with A23187 and phorbol myristate acetate, an up-regulation of SCF mRNA was noted in HMC-1 and KU-812 cells, without changes in the relationship of the two splice variants. The differential expression of SCF-specific mRNA splice variants in immature and mature human mast cells and the secretion of this molecule by these cells may play a role in autocrine stimulation, maintenance of survival and the differentiation of tissue mast cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320642     DOI: 10.1046/j.1365-3083.1999.00519.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

Review 1.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

2.  Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells.

Authors:  P Welker; J Grabbe; B Gibbs; T Zuberbier; B M Henz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 3.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

4.  C-Kit receptor (CD117) in the porcine urinary tract.

Authors:  Roman Metzger; Anja Neugebauer; Udo Rolle; Levin Böhlig; Holger Till
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

5.  Skipping of exons by premature termination of transcription and alternative splicing within intron-5 of the sheep SCF gene: a novel splice variant.

Authors:  Siva Arumugam Saravanaperumal; Dario Pediconi; Carlo Renieri; Antonietta La Terza
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

6.  Human endothelial cells regulate survival and proliferation of human mast cells.

Authors:  C T Mierke; M Ballmaier; U Werner; M P Manns; K Welte; S C Bischoff
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

7.  Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.

Authors:  P Welker; D Schadendorf; M Artuc; J Grabbe; B M Henz
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

8.  Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma.

Authors:  Safaa I Tayel; Sally M El-Hefnway; Eman M Abd El Gayed; Gehan A Abdelaal
Journal:  Respir Res       Date:  2017-01-18

9.  Assessment of stem cell factor expression and its c-KIT receptor in patients with vitiligo.

Authors:  Dorota Wilamowska-Kokoszko; Karolina Łukasik; Jacek C Szepietowski; Dariusz J Skarżynski; Agnieszka Owczarczyk-Saczonek; Justyna Hlebowicz-Skrodzka; Waldemar J Placek
Journal:  Postepy Dermatol Alergol       Date:  2021-10-22       Impact factor: 1.664

10.  Role of keratinocytes in the development of vitiligo.

Authors:  Ai-Young Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.